A5040759015- Cancer Immunotherapy and Biomarkers
- Cancer Genomics and Diagnostics
- Ferroptosis and cancer prognosis
- Colorectal Cancer Treatments and Studies
- Ultrasound in Clinical Applications
- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Cancer, Lipids, and Metabolism
- Bone Metabolism and Diseases
- Bioinformatics and Genomic Networks
- Airway Management and Intubation Techniques
- Radiology practices and education
- Cytokine Signaling Pathways and Interactions
- Radiation Dose and Imaging
- Melanoma and MAPK Pathways
- Cardiac, Anesthesia and Surgical Outcomes
- Trauma Management and Diagnosis
- Urologic and reproductive health conditions
- Prostate Cancer Treatment and Research
- Cancer Cells and Metastasis
- Renal cell carcinoma treatment
- Radiomics and Machine Learning in Medical Imaging
- Bone health and treatments
Tango Therapeutics (United States)
2024-2025
Jinan Central Hospital
2021-2022
Shandong First Medical University
2021-2022
Icahn School of Medicine at Mount Sinai
2012-2016
Elmhurst Hospital Center
2014
Bridge University
2012
Prostate cancer (PCa) is unique in its tendency to produce osteoblastic (OB) bone metastases. There are no existing therapies that specifically target the OB phase affects 90% of men with metastatic disease. Prostatic acid phosphatase (PAP) secreted by PCa cells metastases and increases growth, differentiation, mineralization. The purpose this study was investigate whether PAP effects on mediated autocrine and/or paracrine alterations receptor activator nuclear factor κ-B (RANK)/RANK ligand...
Cytotoxic T cells expressing cell surface CD8 played a key role in anti-cancer immunotherapy, including kidney renal clear carcinoma (KIRC). Here we set out to comprehensively analyze and evaluate the significance of CD8+ cell-related markers for patients with KIRC. We checked immune response KIRC identified type-specific related pathways tumor-infiltrating (TIL-CD8T) cells. used these explore their prognostic signatures TIL-CD8+ by evaluating efficacy group differences at various levels....
The biological functional network of tumor tissues is relatively stable for a period time and under different conditions, so the impact heterogeneity effectively avoided. Based on edge perturbation, gene interaction networks were used to reveal pathological environment patients with non-small cell carcinoma at individual level, identify cancer subtypes same or similar status, then multi-dimensional multi-omics comprehensive analysis was put into practice. Two perturbation identified through...
This study was designed to clarify the prognostic value of tumor microenvironment score and abnormal genomic alterations in TME for breast cancer patients.
marker of increased intracranial pressure (ICP).Only few studies were made correlating MRI measurment ONSD with ultrasound ONSD.Overall lower standard values the for compared to found.That might be atribbuted variable interpretation anatomywhat are we really measuring?Objective: We performed a proof concept study evaluate accuracy measurments contrast enhanced (CEUS) and magnetic resonance imaging (MRI).Second generation agent (Sonovue™, Bracco SpA) was used enhance recognition relevant...
An abstract is not available for this content so a preview has been provided. As you have access to content, full PDF via the ‘Save PDF’ action button.
You have accessJournal of UrologyModerated Poster, Sunday, May 21, 2006, 3:30 - 5:30 pm1 Apr 2006541: CD90 As A Marker for Tumor-Associated Stromal Cells the Prostate Alvin Y. Liu, Hui Zhang, Alan Huang, Peter S. Nelson, and Lawrence D. True LiuAlvin Liu More articles by this author , ZhangHui Zhang HuangAlan Huang NelsonPeter Nelson TrueLawrence View All Author Informationhttps://doi.org/10.1016/S0022-5347(18)32787-3AboutPDF ToolsAdd to favoritesDownload CitationsTrack...